Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117193) titled 'Efficacy and Safety of Semaglutide drug in Stroke' on Sept. 8.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Active Controlled Trial Method of generating randomization sequence:Permuted block randomization, variable Method of allocation concealment:An Open list of random numbers Blinding and masking:Open Label
Primary Sponsor: AIIMS intramural funding
Condition:
Health Condition 1: I633- Cerebral infarction due to thrombosis of cerebral arteries
Intervention:
Intervention1: Semaglutide: Weekly Injectable Semaglutide 0.5mg subcutaneous for 4 weeks
Control Intervention1: Standa...